Filing Details
- Accession Number:
- 0001209191-12-018530
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-15 16:25:09
- Reporting Period:
- 2012-03-14
- Filing Date:
- 2012-03-15
- Accepted Time:
- 2012-03-15 16:25:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Adventrx Pharmaceuticals Inc | ANX | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1310683 | M Brian Culley | 12390 El Camino Real, Suite 150 San Diego CA 92130 | Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-14 | 20,500 | $0.59 | 34,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions executed by a broker-dealer at prices ranging from $0.5900 to $0.5910, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
